Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate versus nalbuphine for hemodynamic responses to orotracheal intubation
PACTR201703002107862Recruiting
- Sponsor
- doaa rashwan
- Start
- Apr 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of magnesium sulfate and nalbuphine in Hemodynamic response to endotracheal intubation (2 arms), sponsored by doaa rashwan. Primary endpoint: mean arterial blood pressure. Started Apr 2017; status: recruiting.
02
Drugs
magnesium sulfatenalbuphine
03
Conditions
Hemodynamic response to endotracheal intubation
Beyond the preview
Go deeper on PACTR201703002107862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201703002107862.